{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:19:53Z","timestamp":1790011193929,"version":"4.0.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019004","name":"Jordan University of Science and Technology Deanship of Research","doi-asserted-by":"publisher","award":["119\/2020"],"award-info":[{"award-number":["119\/2020"]}],"id":[{"id":"10.13039\/501100019004","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021772","name":"Deanship of Scientific Research, University of Jordan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021772","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004035","name":"Jordan University of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004035","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.amjcard.2023.06.108","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T11:21:12Z","timestamp":1689938472000},"page":"73-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Evaluating Plasma Galectin-3 Levels in Patients With an Increased Risk of Atherosclerotic Cardiovascular Disease Who Underwent Coronary Artery Revascularization"],"prefix":"10.1016","volume":"203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2086-7205","authenticated-orcid":false,"given":"Fadia","family":"Mayyas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2023.06.108_bib0001","doi-asserted-by":"crossref","first-page":"9232","DOI":"10.3390\/ijms21239232","article-title":"Galectin-3 in cardiovascular diseases","volume":"21","author":"Blanda","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.amjcard.2023.06.108_bib0002","first-page":"e596","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2023.06.108_bib0003","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1177\/1074248417753677","article-title":"Atorvastatin reduces plasma inflammatory and oxidant biomarkers in patients with risk of atherosclerotic cardiovascular disease","volume":"23","author":"Mayyas","year":"2018","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.amjcard.2023.06.108_bib0004","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3109\/07853890.2010.538080","article-title":"Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction","volume":"43","author":"de Boer","year":"2011","journal-title":"Ann Med"},{"key":"10.1016\/j.amjcard.2023.06.108_bib0005","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00392-010-0125-y","article-title":"Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study","volume":"99","author":"Lok","year":"2010","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.amjcard.2023.06.108_bib0006","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5284728","article-title":"Galectin-3 is a potential mediator for atherosclerosis","volume":"2020","author":"Gao","year":"2020","journal-title":"J Immunol Res"},{"key":"10.1016\/j.amjcard.2023.06.108_bib0007","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jacl.2014.07.007","article-title":"National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 - executive summary","volume":"8","author":"Jacobson","year":"2014","journal-title":"J Clin Lipidol"},{"issue":"suppl","key":"10.1016\/j.amjcard.2023.06.108_bib0008","article-title":"National Lipid Association recommendations for patient-centered management of dyslipidemia: part 2 [published correction appears in J Clin Lipidol 2016;10:211]","volume":"9","author":"Jacobson","year":"2015","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.amjcard.2023.06.108_bib0009","first-page":"e344","volume":"130","author":"Amsterdam","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2023.06.108_bib0010","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1161\/CIR.0000000000000404","volume":"134","author":"Levine","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2023.06.108_bib0011","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1016\/j.jacc.2018.11.005","volume":"73","author":"Lloyd-Jones","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.06.108_bib0012","doi-asserted-by":"crossref","first-page":"e1162","DOI":"10.1161\/CIR.0000000000000638","volume":"139","author":"Lloyd-Jones","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2023.06.108_bib0013","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.15420\/ecr.2020.49","article-title":"The role of C-reactive protein in patient risk stratification and treatment","volume":"16","author":"Arroyo-Espliguero","year":"2021","journal-title":"Eur Cardiol"},{"key":"10.1016\/j.amjcard.2023.06.108_bib0014","doi-asserted-by":"crossref","first-page":"e09836","DOI":"10.1016\/j.heliyon.2022.e09836","article-title":"Plasma lipoprotein (a) and tissue plasminogen activator are associated with increased risk of atherosclerotic cardiovascular disease","volume":"8","author":"Mayyas","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.amjcard.2023.06.108_bib0015","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/clc.23105","article-title":"Association of galectin-3 with markers of myocardial function, atherosclerosis, and vascular fibrosis in patients with rheumatoid arthritis","volume":"42","author":"Anyfanti","year":"2019","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.amjcard.2023.06.108_bib0016","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1136\/jim-2015-000041","article-title":"Is galectin-3 a biomarker, a player-or both-in the presence of coronary atherosclerosis?","volume":"64","author":"Aksan","year":"2016","journal-title":"J Investig Med"},{"key":"10.1016\/j.amjcard.2023.06.108_bib0017","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/tox.22750","article-title":"Galectin-3 aggravates ox-LDL-induced endothelial dysfunction through LOX-1 mediated signaling pathway","volume":"34","author":"Ou","year":"2019","journal-title":"Environ Toxicol"},{"key":"10.1016\/j.amjcard.2023.06.108_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2019.04.049","article-title":"Negative risk markers for cardiovascular events in the elderly","volume":"74","author":"Mortensen","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.06.108_bib0019","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/ATVBAHA.107.159160","article-title":"Galectin-3 is an amplifier of inflammation in atherosclerotic plaque progression through macrophage activation and monocyte chemoattraction","volume":"28","author":"Papaspyridonos","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.amjcard.2023.06.108_bib0020","article-title":"Association between serum galectin-3 levels and coronary stenosis severity in patients with coronary artery disease","volume":"9","author":"Li","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.amjcard.2023.06.108_bib0021","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.5551\/jat.12856","article-title":"Value and level of galectin-3 in acute myocardial infarction patients undergoing primary percutaneous coronary intervention","volume":"19","author":"Tsai","year":"2012","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.amjcard.2023.06.108_bib0022","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.21608\/ejhm.2019.27413","article-title":"Galectin-3 and severity of the coronary artery disease in ischemic patients guided by coronary angiography","volume":"74","author":"Bastawesy","year":"2019","journal-title":"Egypt J Hosp Med"},{"key":"10.1016\/j.amjcard.2023.06.108_bib0023","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7252943","article-title":"Inhibition of galectin-3 alleviates cigarette smoke extract-induced autophagy and dysfunction in endothelial progenitor cells","volume":"2019","author":"Pei","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.amjcard.2023.06.108_bib0024","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001894","article-title":"Serum galectin-3BP as a novel marker of obesity and metabolic syndrome in Chinese adolescents","volume":"9","author":"Zhen","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.amjcard.2023.06.108_bib0025","first-page":"129","article-title":"Galectin-3: a novel biomarker for the prognosis of heart failure","volume":"90","author":"Amin","year":"2017","journal-title":"Clujul Med"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914923005209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914923005209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:47:19Z","timestamp":1757573239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914923005209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":25,"alternative-id":["S0002914923005209"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2023.06.108","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating Plasma Galectin-3 Levels in Patients With an Increased Risk of Atherosclerotic Cardiovascular Disease Who Underwent Coronary Artery Revascularization","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2023.06.108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}